5:28 PM ET
8-K
Capital Raise
Viking Therapeutics Capital Raise of $316M
Viking Therapeutics closed a public equity offering of 9,035,714 shares of common stock at $35.00 per share, including the full exercise of the underwriters' overallotment option. The company raised approximately $297.0 million in net proceeds from the equity portion. Simultaneously, the company issued $258.75 million in 2.00% Convertible Senior Notes due 2032 to further strengthen its balance sheet.
- Value
- $316M
- Counterparty
- Morgan Stanley & Co. LLC and J.P. Morgan Securities LLC